Chengdu Kanghong Pharmaceutical Group Co (SZSE:002773) EBIT per Share : ¥1.40 (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Chengdu Kanghong Pharmaceutical Group Co EBIT per Share?

Chengdu Kanghong Pharmaceutical Group Co's EBIT per Share for the three months ended in Mar. 2025 was ¥0.48. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1.40.

During the past 12 months, the average EBIT per Share Growth Rate of Chengdu Kanghong Pharmaceutical Group Co was 0.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was 35.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Chengdu Kanghong Pharmaceutical Group Co's EBIT per Share or its related term are showing as below:

SZSE:002773' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -12.8 Med: 15.9 Max: 35.8
Current: 35.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Chengdu Kanghong Pharmaceutical Group Co was 35.80% per year. The lowest was -12.80% per year. And the median was 15.90% per year.

SZSE:002773's 3-Year EBIT Growth Rate is ranked better than
80.12% of 825 companies
in the Drug Manufacturers industry
Industry Median: 8.3 vs SZSE:002773: 35.80

Chengdu Kanghong Pharmaceutical Group Co's EBIT for the three months ended in Mar. 2025 was ¥451 Mil.

Chengdu Kanghong Pharmaceutical Group Co EBIT per Share Historical Data

The historical data trend for Chengdu Kanghong Pharmaceutical Group Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Kanghong Pharmaceutical Group Co EBIT per Share Chart

Chengdu Kanghong Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.60

0.43

1.02

1.27

1.39

Chengdu Kanghong Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.47	0.37	0.34	0.21	0.48

Chengdu Kanghong Pharmaceutical Group Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Chengdu Kanghong Pharmaceutical Group Co's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1274.697	/	916.331
=	1.39

Chengdu Kanghong Pharmaceutical Group Co's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	450.635	/	930.274
=	0.48

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.40

Chengdu Kanghong Pharmaceutical Group Co (SZSE:002773) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Chengdu Kanghong Pharmaceutical Group Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Chengdu Kanghong Pharmaceutical Group Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Kanghong Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengdu Kanghong Pharmaceutical Group Co Ltd (SZSE:002773) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No.36, West Road, Jinniu District, Sichuan, Chengdu, CHN, 610036

Website

http://www.cnkh.com

Chengdu Kanghong Pharmaceutical Group Co Ltd is a pharmaceutical company. The company is engaged in the research and development, production, and sales of medicine, chemical medicine, and biological products.

Executives

Ke Xiao	Directors, executives
Zhong Jian Jun	Directors, executives
Yin Jin Qun	Directors, executives
Ke Zun Hong	Director
Zhong Jian Rong	Directors, executives
Gong Wen Xian	Supervisors
Yuan Si Xu	Supervisors
Zhao Xing Ping	Directors, executives
Hao Xiao Feng	Directors, executives

Chengdu Kanghong Pharmaceutical Group Co Headlines

No Headlines